Literature DB >> 9584962

A conceptual framework for explaining drug addiction.

N Heather1.   

Abstract

The aim of this paper is to describe a conceptual framework of questions which an adequate theory of drug addiction must attempt to answer. First, a satisfactory definition of addiction is sought and it is concluded that it is best defined by repeated failures to refrain from drug use despite prior resolutions to do so. This definition is consistent with views of addiction that see decision-making, ambivalence and conflict as central features of the addict's behaviour and experience. On this basis, a three-level framework of required explanation is set out, consisting of (1) the level of neuroadaptation, (2) the level of desire for drugs and (3) the level of 'akrasia'or failures of resolve. The crucial argument is made that explanatory concepts used at the'lower' levels in this framework can never be held to be sufficient as explanations at higher levels, i.e. the postulation of additional determinants is always required at Levels 2 and 3. In particular, it is a failure to address problems at the highest level in the framework that marks the inadequacy of most existing theories of addiction. The paper concludes by considering the relevance of the ideas presented to the concept of 'compulsive drug use' and concludes that this concept is no longer useful in the explanation of addiction.

Entities:  

Mesh:

Year:  1998        PMID: 9584962     DOI: 10.1177/026988119801200101

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  18 in total

1.  Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement.

Authors:  Jesse Dallery; Bethany R Raiff
Journal:  Psychopharmacology (Berl)       Date:  2007-01-05       Impact factor: 4.530

2.  Is contemplation a separate stage of change to precontemplation?

Authors:  James Balmford; Ron Borland; Sue Burney
Journal:  Int J Behav Med       Date:  2008

3.  Individual Differences in Approach and Avoidance Inclinations Moderate the Effect of Self-Control Depletion on Ad-Lib Drinking.

Authors:  Robert C Schlauch; Rita L Christensen; Jaye L Derrick; Cory A Crane; R Lorraine Collins
Journal:  Alcohol Clin Exp Res       Date:  2015-12       Impact factor: 3.455

4.  Women Inmate Substance Abusers' Reactivity to Visual Alcohol, Cigarette, Marijuana, and Crack-Cocaine Cues: Approach and Avoidance as Separate Dimensions of Reactivity.

Authors:  Robert C Schlauch; Mary J Breiner; Paul R Stasiewicz; Rita L Christensen; Alan R Lang
Journal:  J Psychopathol Behav Assess       Date:  2012-08-14

5.  Affect and craving: positive and negative affect are differentially associated with approach and avoidance inclinations.

Authors:  Robert C Schlauch; Daniel Gwynn-Shapiro; Paul R Stasiewicz; Danielle S Molnar; Alan R Lang
Journal:  Addict Behav       Date:  2012-12-08       Impact factor: 3.913

6.  Facial reactions to smoking cues relate to ambivalence about smoking.

Authors:  Kasey M Griffin; Michael A Sayette
Journal:  Psychol Addict Behav       Date:  2008-12

7.  The role of craving in the treatment of alcohol use disorders: The importance of competing desires and pretreatment changes in drinking.

Authors:  Robert C Schlauch; Cory A Crane; Gerard J Connors; Ronda L Dearing; Stephen A Maisto
Journal:  Drug Alcohol Depend       Date:  2019-04-25       Impact factor: 4.492

Review 8.  Dopamine Prediction Errors in Reward Learning and Addiction: From Theory to Neural Circuitry.

Authors:  Ronald Keiflin; Patricia H Janak
Journal:  Neuron       Date:  2015-10-21       Impact factor: 17.173

9.  Is the concept of compulsion useful in the explanation or description of addictive behaviour and experience?

Authors:  Nick Heather
Journal:  Addict Behav Rep       Date:  2017-05-18

10.  To approach or avoid alcohol? Automatic and self-reported motivational tendencies in alcohol dependence.

Authors:  Helen Barkby; Joanne M Dickson; Louise Roper; Matt Field
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.